Definitive Healthcare (NASDAQ:DH) Stock Price Up 4.9%

Definitive Healthcare Corp. (NASDAQ:DH)’s share price rose 4.9% on Tuesday . The stock traded as high as $6.02 and last traded at $6.00. Approximately 72,200 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 695,588 shares. The stock had previously closed at $5.72.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on DH shares. Canaccord Genuity Group reduced their target price on Definitive Healthcare from $10.00 to $8.00 and set a “hold” rating on the stock in a research note on Wednesday, May 8th. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research report on Wednesday, May 8th. Stifel Nicolaus cut their price target on shares of Definitive Healthcare from $11.00 to $9.50 and set a “buy” rating for the company in a research report on Wednesday, May 8th. Barclays cut their price target on shares of Definitive Healthcare from $11.00 to $7.00 and set an “equal weight” rating for the company in a research report on Thursday, May 9th. Finally, William Blair restated an “outperform” rating on shares of Definitive Healthcare in a research report on Tuesday, May 14th. Eight research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $9.56.

Definitive Healthcare Stock Up 2.1 %

The stock’s 50 day simple moving average is $5.53 and its two-hundred day simple moving average is $7.24. The firm has a market cap of $702.86 million, a P/E ratio of -3.41, a P/E/G ratio of 4.36 and a beta of 1.30. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.30 and a quick ratio of 2.30.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Tuesday, May 7th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.04). The firm had revenue of $63.48 million for the quarter, compared to the consensus estimate of $64.00 million. Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. As a group, research analysts forecast that Definitive Healthcare Corp. will post 0.1 earnings per share for the current year.

Institutional Investors Weigh In On Definitive Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in DH. Tower Research Capital LLC TRC boosted its stake in shares of Definitive Healthcare by 599.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,786 shares of the company’s stock worth $58,000 after acquiring an additional 4,959 shares during the last quarter. Norden Group LLC purchased a new position in shares of Definitive Healthcare during the 1st quarter worth $83,000. Berry Wealth Group LP purchased a new position in shares of Definitive Healthcare during the 1st quarter worth $99,000. Susquehanna Fundamental Investments LLC purchased a new position in shares of Definitive Healthcare during the 1st quarter valued at $120,000. Finally, Hennion & Walsh Asset Management Inc. purchased a new position in shares of Definitive Healthcare during the 2nd quarter valued at $127,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.